For the Inventor, By the Inventor

Enter assignee name

Napa, CA, United States of America

Transvivo, Inc.

USPTO Granted Patents = 19

% Expired Patents = 73.7

EPO Patents = 1

Forward Citations = 740

Loading Chart...

Loading Chart...

7 inventors (with patents filed for the assignee):

Reynolds G Gorsuch (19 out of 29 patents)

Harold W Peters (9 out of 15 patents)

Harold H Handley, Jr (9 out of 9 patents)

4. Tommy Gene Cooper (5 out of 20 patents)

5. Henry M Grage (4 out of 18 patents)

6. Jacob C Kearns (3 out of 3 patents)

7. Kris Venkat (3 out of 3 patents)

8. Harold H Handley (7 patents)

19 patents: Sort by Forward Citations

1. 8070706 - Apparatus and method for in-vivo plasmapheresis using periodic backflush containing anticoagulant (2011-12-06),

2. 7585412 - Specialized hollow fiber membranes for plasmapheresis and ultrafiltration (2009-09-08),

3. 7572374 - Anticoagulant and thrombo-resistant hollow fiber membranes for in-vivo plasmapheresis and ultrafiltration (2009-08-11),

4. 7481936 - Method and apparatus for patient fluid management (2009-01-27),

5. 7476210 - Apparatus and method for in-vivo plasmapheresis using periodic backflush containing anticoagulant (2009-01-13),

6. 7354392 - Structurally optimized hollow fiber membranes (2008-04-08),

7. 7267771 - Apparatus for therapeutic apheresis (2007-09-11),

8. 7195711 - Specialized hollow fiber membranes for in-vivo plasmapheresis and ultrafiltration (2007-03-27),

9. 6949078 - Apparatus and method for selective reduction of segmental intracellular and extracellular edema (2005-09-27),

10. 6899692 - Plasmapheresis filter device and catheter assembly (2005-05-31),

11. 6849183 - Method and apparatus for therapeutic apheresis (2005-02-01),

12. 6802971 - Specialized hollow fiber membranes for in-vivo plasmapheresis and ultrafiltration (2004-10-12),

13. 6802820 - Specialized hollow fiber membranes for in-vivo plasmapheresis and ultrafiltration (2004-10-12),

14. 6659973 - Apparatus and method for in-vivo plasmapheresis using periodic backflush (2003-12-09),

15. 6632192 - Apparatus and method for selective reduction of segmental intracellular and extracellular edema (2003-10-14),

Transvivo, Inc. is a leading biotech company focused on the development and production of innovative vaccines. With a diverse portfolio of products, Transvivo is committed to delivering safe and effective immunization solutions to tackle global health challenges. Our cutting-edge research, state-of-the-art facilities, and dedicated team of experts enable us to push the boundaries of science and improve global public health. Visit our website to learn more about our groundbreaking initiatives and collaborations.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 15 2026

Transvivo, Inc.

19 Patents

#3 in Napa, CA

#4,091 in California

#17,096 in US

#32,555 in the World

Napa, CA, United States of America

Transvivo, Inc.

Forward Citations = 740

7 inventors:

Reynolds G Gorsuch (19 out of 29 patents)

Harold W Peters (9 out of 15 patents)

Harold H Handley, Jr (9 out of 9 patents)

4. Tommy Gene Cooper (5 out of 20 patents)

5. Henry M Grage (4 out of 18 patents)

Please report any incorrect information to [email protected]

Loading…